Skip to main content
Biotest Aktiengesellschaft (ETR:BIO)
Germany flag Germany · Delayed Price · Currency is EUR
42.60
0.00 (0.00%)
May 9, 2025, 5:35 PM CET

ETR:BIO Revenue

In the year 2024, Biotest Aktiengesellschaft had annual revenue of 726.20M EUR with 6.08% growth. Biotest Aktiengesellschaft had revenue of 203.50M in the quarter ending December 31, 2024, with 10.42% growth.

Revenue
726.20M
Revenue Growth
+6.08%
P/S Ratio
1.98
Revenue / Employee
291.06K
Employees
2,495
Market Cap
1.44B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024726.20M41.60M6.08%
Dec 31, 2023684.60M168.50M32.65%
Dec 31, 2022516.10M500.00K0.10%
Dec 31, 2021515.60M31.40M6.48%
Dec 31, 2020484.20M65.10M15.53%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck KGaA 21.16B
Siemens Healthineers AG 23.14B
Fresenius SE & Co. KGaA 22.13B
Bayer Aktiengesellschaft 46.61B
Fresenius Medical Care AG 19.49B
Sartorius Aktiengesellschaft 3.44B
Carl Zeiss Meditec AG 2.08B
Fielmann Group AG 2.26B
Revenue Rankings

Biotest Aktiengesellschaft News

More News